Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM16277
Volume:
6 |
9 |
Sep 2022
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Hepatocellular carcinoma (HCC) is the fifth common tumor worldwide. In the United States, HCC is that the ninth leading cause of cancer deaths. HCC is the primary liver malignancy and could be a leading reason for cancer related death worldwide. Despite advances in prevention techniques, screening, and new technologies in both diagnosis and treatment, incidence and mortality still rise. HCC remains a global health challenge, with an estimated prevalence of >1 million cases by 2025. Multiple treatment options are available for HCC including liver transplantation (LT), radiofrequency ablation (RFA), trans arterial chemoembolization (TAF), radioembolization and systemic targeted agent like sorafenib. The treatment for HCC depends on the tumour stage, patient performance status. Among the past few years with significant advances in surgical treatments and locoregional therapies, the short-term survival of HCC has improved but the recurrent disease remains an enormous problem. Little progress has been made for this cancer, whose mortality is 100 % at 10 years. Progression from infection to cirrhosis takes average 20 years. The present study deals various medicinal plants that have a Pharmacological effect on HCC.
KEYWORDS
Publication Date
7/8/2022
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
1
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...